2024. Dupilumab Improves Patient-Reported Outcomes as Early as 1 Month among Adults with Prurigo Nodularis in Clinical Practice: Initial Results from the RELIEVE-PN Study. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s506. DOI:https://doi.org/10.25251/skin.8.supp.506.